Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
6.03
-0.04 (-0.66%)
Nov 20, 2024, 4:00 PM EST - Market open
Coya Therapeutics Employees
Coya Therapeutics had 8 employees as of December 31, 2023. The number of employees increased by 2 or 33.33% compared to the previous year.
Employees
8
Change (1Y)
2
Growth (1Y)
33.33%
Revenue / Employee
$1,194,289
Profits / Employee
-$1,337,380
Market Cap
94.60M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 8 | 2 | 33.33% |
Dec 31, 2022 | 6 | 0 | - |
Dec 31, 2021 | 6 | - | - |
Related Stocks
Company Name | Employees |
---|---|
So-Young International | 1,357 |
Harvard Bioscience | 416 |
Coherus BioSciences | 306 |
PetMed Express | 287 |
Quantum-Si incorporated | 159 |
Regulus Therapeutics | 30 |
Genelux | 23 |
Relmada Therapeutics | 20 |
COYA News
- 2 days ago - Coya Therapeutics CEO Dr. Arun Swaminathan Issues Letter to Stockholders - Business Wire
- 15 days ago - Coya Therapeutics Provides a Corporate Update and Reports Unaudited Third Quarter 2024 Financial Results - Business Wire
- 20 days ago - Coya Therapeutics Announces Arun Swaminathan, Ph.D. Assumes New Role as Chief Executive Officer - Business Wire
- 21 days ago - Coya Therapeutics: Buying The Dip After Unwarranted Sell-Off - Seeking Alpha
- 22 days ago - Coya Therapeutics' High-Dose Interleukin-2 Misses The Mark In Mid-Stage Alzheimer's Study - Benzinga
- 23 days ago - Coya Therapeutics reports positive immune response, safety in mid-stage Alzheimer's drug trial - Reuters
- 23 days ago - Coya Therapeutics Announces Positive Results of a Double-Blind Study of Subcutaneous Low-Dose Interleukin-2 (LD IL-2) in Alzheimer's Disease (AD) Presented at the Clinical Trials on Alzheimer's Disease Conference (CTAD24) in Madrid (Spain) - Business Wire
- 24 days ago - Coya Therapeutics Announces Conference Call to Report Results from an Investigator-Initiated Phase 2 Trial of Low-Dose Interleukin-2 in Patients with Mild to Moderate Alzheimer's Disease - Business Wire